Allergic Bronchopulmonary Aspergillosis: An Occult Disease Waiting To Be Explored- Case Report And Review Of Literature
Allergic Bronchopulmonary Aspergillosis: An Occult Disease Waiting To Be Explored
Keywords:
Allergic bronchopulmonary aspergillosis (ABPA), Aspergillus fumigatusAbstract
Allergic bronchopulmonary aspergillosis (ABPA) is a slowly progressive disease caused by hypersensitivity to Aspergillus fumigatus. This condition is most commonly seen in patients with asthma and cystic fibrosis. ABPA mimics a wide range of diseases, thereby further accentuating the difficulties faced by medical practitioners in diagnosing this condition. Even today, this condition remains under diagnosed in many countries with reports of mean diagnostic latency of ten years between the occurrence of symptoms and the diagnosis. We present a case report and review of literature with the aim of highlighting the complicated nature of this enigmatic illness. [Bhatia M NJIRM 2015; 6(6):106-112]
References
1. Greenberger PA. Clinical aspects of allergic bronchopulmonary aspergillosis. Front Biosci 2003; 8:119 –127
2. David W.D. Aspergillosis. In: Kasper DL, Fauci AS (eds.), Harrison’s Infectious Diseases, 2nd ed, New York, McGraw Hill, 2013, pp.1090-96
3. Kirsten D, Nowak D, Rabe KF. Diagnosis of bronchopulmonary aspergillosis is often made too late. Med Klin 1993; 88:353–56
4. Hinson KFW, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis; a review and a report of eight new cases.Thorax 1952; 7:317–33
5. Bedi R S, Bedi GK. Allergic bronchopulmonary aspergillosis: Indian scenario. Lung India 2007;24:156-61
6. Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in North India. Chest 2006;130:442–48
7. Maurya V, Gagnani HC, Sarma PV, Madan T, Shah A. Sensitization to aspergillus antigens and occurrence of bronchopulmonary aspergillosis in patients with asthma. Chest 2005;127:1252-59
8. Kumar R, Gaur SN. Prevalence of Allergic bronchopulmonary aspergillosis in patients with bronchial asthma. Asian P J Allergy Immunol 2000;18:181-859. Rajan TV. The Gell-Coombs classification of hypersensitivity reactions: A re-interpretation. Trends Immunol 2003; 24:376 –79
10. de Oliveira E, Giavina-Bianchi P, Fonseca LAM, Francxa AT, Kalil J. Allergic bronchopulmonary aspergillosis’ diagnosis remains a challenge. Respir Med 2007;101:2352–57
11. Ganassini A, Cazzadori A. Invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis. Respir Med 1995;89:143–45
12. Tillie-Leblond I, Tonnel A-B. Allergic bronchopulmonary aspergillosis. Allergy 2005;60:1004–13
13. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009;135:805–26
14. Backman KS, Roberts M, Patterson R. Allergic bronchopulmonary mycosis caused by fusarium vasinfectum. Am J Respir Crit Care Med 1995;152:1379–81
15. Patterson R, Greenberger PA, Halwig M, Liotta JL, Roberts M. Allergic bronchopulmonary aspirgillosis: natural history and classification of early diagnosis by serologic and roentgenographic studies. Arch Intern Med 1986;146:916–18
16. Rajkumar DP. Evaluation of allergic bronchopulmonary aspergillosis in patients with and without central bronchiectasis. JAsthma2002;39:473–77
17. Sethi GR, Singhal KK. Pulmonary diseases and corticosteroids. Indian J Pediatr 2008;75:1045–56
18. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, Denning DW, Crameri R, Brody AS, Light M, Skov M, Maish W, Mastella G; Cystic Fibrosis Foundation Consensus Conference. Allergic bronchopulmonary aspergillosis in cystic fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003;37:225–64
19. Vlahakis NE, Aksamit TR. Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc 2001;76:930–38
20. Rai SP, Panda BN, Bhargva S. Treatment of allergic bronchopulmonary aspergillosis with fluconazole and itraconazole. MJAFI 2004;60:128-30
21. Ruth A, Rosemary A. B, Elizabeth M. J, Malcolm D. R, Rebecca G, William W. H. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology H. J Antimicrob Chemother 2014;69:1162-76
22. Camuset J, Nunes H, Dombret M-C, Bergeron A, Henno P, Philippe B, Dauriat G, Mangiapan G, Rabbat A, Cadranel J. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocomprised patients. Chest 2007;131:1435–41
23. Kanu A, Patel K. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab). Pediatr Pulmonol 2008;43:1249–51
24. Andrew H. Limper "The Changing Spectrum of Fungal Infections In Pulmonary and Critical Care Practice", Proceedings of the American Thoracic Society, 2010; 7(3): pp. 163-68
25. Michael A.P. Clinical Mycology. In: Richard K.R, Francis W, Lawrence C, Walter E.S (eds.), Clinical Infectious Diseases-A Practical Approach, New York, Oxford university Press, 1999, pp.169-80
26. Foula V , Aikaterini S , Athanassia D , Georgios P , Stavros A, Demosthenes B. Mixed Allergic Bronchopulmonary Aspergillosis and Candidiasis. PNEUMON 2014; 27(2): 6-10
2. David W.D. Aspergillosis. In: Kasper DL, Fauci AS (eds.), Harrison’s Infectious Diseases, 2nd ed, New York, McGraw Hill, 2013, pp.1090-96
3. Kirsten D, Nowak D, Rabe KF. Diagnosis of bronchopulmonary aspergillosis is often made too late. Med Klin 1993; 88:353–56
4. Hinson KFW, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis; a review and a report of eight new cases.Thorax 1952; 7:317–33
5. Bedi R S, Bedi GK. Allergic bronchopulmonary aspergillosis: Indian scenario. Lung India 2007;24:156-61
6. Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in North India. Chest 2006;130:442–48
7. Maurya V, Gagnani HC, Sarma PV, Madan T, Shah A. Sensitization to aspergillus antigens and occurrence of bronchopulmonary aspergillosis in patients with asthma. Chest 2005;127:1252-59
8. Kumar R, Gaur SN. Prevalence of Allergic bronchopulmonary aspergillosis in patients with bronchial asthma. Asian P J Allergy Immunol 2000;18:181-859. Rajan TV. The Gell-Coombs classification of hypersensitivity reactions: A re-interpretation. Trends Immunol 2003; 24:376 –79
10. de Oliveira E, Giavina-Bianchi P, Fonseca LAM, Francxa AT, Kalil J. Allergic bronchopulmonary aspergillosis’ diagnosis remains a challenge. Respir Med 2007;101:2352–57
11. Ganassini A, Cazzadori A. Invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis. Respir Med 1995;89:143–45
12. Tillie-Leblond I, Tonnel A-B. Allergic bronchopulmonary aspergillosis. Allergy 2005;60:1004–13
13. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009;135:805–26
14. Backman KS, Roberts M, Patterson R. Allergic bronchopulmonary mycosis caused by fusarium vasinfectum. Am J Respir Crit Care Med 1995;152:1379–81
15. Patterson R, Greenberger PA, Halwig M, Liotta JL, Roberts M. Allergic bronchopulmonary aspirgillosis: natural history and classification of early diagnosis by serologic and roentgenographic studies. Arch Intern Med 1986;146:916–18
16. Rajkumar DP. Evaluation of allergic bronchopulmonary aspergillosis in patients with and without central bronchiectasis. JAsthma2002;39:473–77
17. Sethi GR, Singhal KK. Pulmonary diseases and corticosteroids. Indian J Pediatr 2008;75:1045–56
18. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, Denning DW, Crameri R, Brody AS, Light M, Skov M, Maish W, Mastella G; Cystic Fibrosis Foundation Consensus Conference. Allergic bronchopulmonary aspergillosis in cystic fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003;37:225–64
19. Vlahakis NE, Aksamit TR. Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc 2001;76:930–38
20. Rai SP, Panda BN, Bhargva S. Treatment of allergic bronchopulmonary aspergillosis with fluconazole and itraconazole. MJAFI 2004;60:128-30
21. Ruth A, Rosemary A. B, Elizabeth M. J, Malcolm D. R, Rebecca G, William W. H. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology H. J Antimicrob Chemother 2014;69:1162-76
22. Camuset J, Nunes H, Dombret M-C, Bergeron A, Henno P, Philippe B, Dauriat G, Mangiapan G, Rabbat A, Cadranel J. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocomprised patients. Chest 2007;131:1435–41
23. Kanu A, Patel K. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab). Pediatr Pulmonol 2008;43:1249–51
24. Andrew H. Limper "The Changing Spectrum of Fungal Infections In Pulmonary and Critical Care Practice", Proceedings of the American Thoracic Society, 2010; 7(3): pp. 163-68
25. Michael A.P. Clinical Mycology. In: Richard K.R, Francis W, Lawrence C, Walter E.S (eds.), Clinical Infectious Diseases-A Practical Approach, New York, Oxford university Press, 1999, pp.169-80
26. Foula V , Aikaterini S , Athanassia D , Georgios P , Stavros A, Demosthenes B. Mixed Allergic Bronchopulmonary Aspergillosis and Candidiasis. PNEUMON 2014; 27(2): 6-10
Downloads
Published
2018-01-15
How to Cite
Bhatia, M., Mishra, B., Thakur, A., Dogra, V., & Loomba, P. S. (2018). Allergic Bronchopulmonary Aspergillosis: An Occult Disease Waiting To Be Explored- Case Report And Review Of Literature: Allergic Bronchopulmonary Aspergillosis: An Occult Disease Waiting To Be Explored. National Journal of Integrated Research in Medicine, 6(6), 106–112. Retrieved from http://nicpd.ac.in/ojs-/index.php/njirm/article/view/1030
Issue
Section
Case Report
